Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD

被引:23
作者
Boixeda, Ramon [1 ,4 ]
Bacca, Sandra [1 ,4 ]
Elias, Lorena [1 ]
Anton Capdevila, Josep [1 ,4 ]
Vila, Xavier [2 ]
Mauri, Montserrat [1 ]
Almirall, Jordi [3 ]
机构
[1] Consorci Sanitari Maresme, Hosp Mataro, Serv Med Interna, Barcelona, Spain
[2] Consorci Sanitari Maresme, Hosp Mataro, Unidad Neumol, Barcelona, Spain
[3] CIBERES, Consorci Sanitari Maresme, Hosp Mataro, Unidad Cuidados Intensivos, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2014年 / 50卷 / 12期
关键词
Chronic obstructive pulmonary disease; Respiratory infection; Acute exacerbation; Pneumonia; Hospitalization; COMMUNITY-ACQUIRED PNEUMONIA; INTENSIVE-CARE-UNIT; RISK;
D O I
10.1016/j.arbres.2014.02.001
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Pneumonia is considered an independent entity in chronic obstructive pulmonary disease (COPD), to be distinguished from an infectious exacerbation of COPD. The aim of this study was to analyze the clinical characteristics and progress of the exacerbation of COPD (ECOPD) compared to pneumonia in COPD (PCOPD) patients requiring hospitalization. Patients and methods: Prospective, longitudinal, observational cohort study including 124 COPD patients requiring hospital admission for lower respiratory tract infection. Patients were categorized according to presence of ECOPD (n = 104) or PCOPD (n = 20), depending on presence of consolidation on X-ray. Demographic, clinical, laboratory, microbiological and progress variables were collected. Results: Patients with ECOPD showed more severe respiratory disease according to the degree of obstruction (P<.01) and need for oxygen therapy (P<.05). PCOPD patients showed increased presence of fever (P<.05), lower blood pressure (P<.001), more laboratory abnormalities (P<.05; leukocytosis, elevated CRP, low serum albumin) and increased presence of crepitus (P<.01). Microbiological diagnosis was achieved in 30.8% of cases of ECOPD and 35% of PCOPD; sputum culture yielded the highest percentage of positive results, predominantly Pseudomonas aeruginosa. Regarding the progress of the episode, no differences were found in hospital stay, need for ICU or mechanical ventilation. Conclusions: Our data confirm clinical and analytical differences between ECOPD and PCOPD in patients who require hospital admission, while there were no differences in subsequent progress. (C) 2013 SEPAR. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:514 / 520
页数:7
相关论文
共 21 条
  • [1] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ANTHONISEN, NR
    MANFREDA, J
    WARREN, CPW
    HERSHFIELD, ES
    HARDING, GKM
    NELSON, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 196 - 204
  • [2] Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD
    Bafadhel, Mona
    Clark, Tristan W.
    Reid, Carlene
    Medina, Marie-jo
    Batham, Sally
    Barer, Michael R.
    Nicholson, Karl G.
    Brightling, Christopher E.
    [J]. CHEST, 2011, 139 (06) : 1410 - 1418
  • [3] COPD stage and risk of hospitalization for infectious disease
    Benfield, Thomas
    Lange, Peter
    Vestbo, Jorgen
    [J]. CHEST, 2008, 134 (01) : 46 - 53
  • [4] Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
    Bestall, JC
    Paul, EA
    Garrod, R
    Garnham, R
    Jones, PW
    Wedzicha, JA
    [J]. THORAX, 1999, 54 (07) : 581 - 586
  • [5] CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77
  • [6] Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study
    Daubin, Cedric
    Parienti, Jean-Jacques
    Fradin, Sabine
    Vabret, Astrid
    Ramakers, Michel
    Terzi, Nicolas
    Freymuth, Francois
    Charbonneau, Pierre
    du Cheyron, Damien
    [J]. BMC INFECTIOUS DISEASES, 2009, 9 : 157
  • [7] Departament de Salut Generalitat de Catalunya, 2009, PLA ACT CAT ENFR INF
  • [8] GesEPOC, 2012, ARCH BRONCONEUMOL S, V48, P2
  • [9] Güngör G, 2010, TUBERK TORAK, V58, P408
  • [10] Pneumonic and Nonpneumonic Exacerbations of COPD Inflammatory Response and Clinical Characteristics
    Huerta, Arturo
    Crisafulli, Ernesto
    Menendez, Rosario
    Martinez, Raquel
    Soler, Nestor
    Guerrero, Monica
    Montull, Beatriz
    Torres, Antoni
    [J]. CHEST, 2013, 144 (04) : 1134 - 1142